Cargando…

The Immune Heterogeneity Between Pulmonary Adenocarcinoma and Squamous Cell Carcinoma: A Comprehensive Analysis Based on lncRNA Model

Adenocarcinoma (AD) and squamous cell carcinoma (SCC) are both classified as major forms of non-small cell lung cancer, but differences in clinical prognoses and molecular mechanisms are remarkable. Recent studies have supported the importance of understanding immune status in that it influences cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Tao, Ma, Guoyuan, Wang, Kai, Liu, Weidong, Zhong, Weiqing, Du, Jiajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358782/ https://www.ncbi.nlm.nih.gov/pubmed/34394068 http://dx.doi.org/10.3389/fimmu.2021.547333

Ejemplares similares

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Sun, Qi, et al.
Publicado: (2021)

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma
por: Yang, Huijie, et al.
Publicado: (2022)

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

The lncRNA Connection Between Cellular Metabolism and Epigenetics in Trained Immunity
por: Fok, Ezio T., et al.
Publicado: (2019)

Effect of LncRNA XIST on Immune Cells of Primary Biliary Cholangitis
por: She, Chunhui, et al.
Publicado: (2022)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma
por: Zhao, Fangchao, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Comprehensive analysis of suppressor of cytokine signaling 2 protein in the malignant transformation of NSCLC
por: Ma, Guoyuan, et al.
Publicado: (2023)

Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma
por: Qiu, Mantang, et al.
Publicado: (2016)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment
por: Wang, Yuanyong, et al.
Publicado: (2022)

Comprehensive analysis of lncRNA-mediated ceRNA networkfor hepatocellular carcinoma
por: Chen, Weiqing, et al.
Publicado: (2022)

Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC
por: Li, Xiawei, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
por: Li, Duguang, et al.
Publicado: (2023)

Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study
por: Sun, Xiuhong, et al.
Publicado: (2021)

Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer
por: Luan, Likun, et al.
Publicado: (2022)

Comprehensive analysis of lncRNA-mRNAs co-expression network identifies potential lncRNA biomarkers in cutaneous squamous cell carcinoma
por: Hu, Yu, et al.
Publicado: (2022)

Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma
por: Wang, Yujia, et al.
Publicado: (2020)

Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas
por: Lin, Zhiheng, et al.
Publicado: (2022)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2021)

Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
por: Xie, Hongjun, et al.
Publicado: (2022)

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature
por: Zhang, Ze, et al.
Publicado: (2022)

Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma
por: Xiao, Junbo, et al.
Publicado: (2022)

Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
por: Huan, Sheng, et al.
Publicado: (2022)

An Exosome-Related Long Non-coding RNA (lncRNA)-Based Signature for Prognosis and Therapeutic Interventions in Lung Adenocarcinoma
por: Li, Jinghong, et al.
Publicado: (2023)

A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer
por: Jiao, Ying, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
por: Chen, Shujia, et al.
Publicado: (2022)

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination
por: You, Weiqiang, et al.
Publicado: (2022)

Comprehensive analysis of lncRNA-associated competing endogenous RNA network and immune infiltration in idiopathic pulmonary fibrosis
por: Wang, Zheng, et al.
Publicado: (2020)

Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients
por: Liu, Junhui, et al.
Publicado: (2021)

Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction
por: Hu, Xin, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kvv8qsb73ngpj2anekdndhl9pe